机译:HER2抗体 - 药物缀合物对血源性异种移植模型中的乳腺癌脑转移的生长控制,具有非均相的血液肿瘤阻隔渗透,而不是被动标记
NCI Womens Malignancies Branch Ctr Canc Res Bethesda MD 20892 USA;
NCI Womens Malignancies Branch Ctr Canc Res Bethesda MD 20892 USA;
NCI Womens Malignancies Branch Ctr Canc Res Bethesda MD 20892 USA;
Frederick Natl Lab Canc Res Lab Anim Sci Program Frederick MD USA;
NCI Womens Malignancies Branch Ctr Canc Res Bethesda MD 20892 USA;
Frederick Natl Lab Canc Res Lab Anim Sci Program Frederick MD USA;
AstraZeneca Oncol R&D Gaithersburg MD USA;
NCI Womens Malignancies Branch Ctr Canc Res Bethesda MD 20892 USA;
antibody-drug conjugate; antibody-tubulysin conjugate; blood-brain barrier; blood-tumor barrier; brain; breast cancer; central nervous system; metastasis; permeability;
机译:乳腺癌脑转移的五个临床前模型中血肿瘤屏障的被动渗透性的表征
机译:异质性血液肿瘤屏障通透性决定了乳腺癌实验性脑转移中的药物疗效。
机译:脂质体Irinotecan积累在转移性病变中,穿过血肿瘤屏障(BTB),并在三重阴性乳腺癌脑转移的实验模型中延长存活
机译:乳腺癌脑转移的五个临床前模型中血肿瘤屏障的被动渗透性的表征
机译:脂质体Irinotecan积累在转移性病变中,穿过血肿瘤屏障(BTB),并在三重阴性乳腺癌的脑转移实验模型中延长存活
机译:mmp-1在异种移植模型中对乳腺癌生长和脑转移的作用。